The commercial vaccines, Gavac and TickGARD, contained the recombinant R. microplus Bm86 gut antigen (Willadsen et al. 1989; Rand et al. 1989; Rodríguez et al. 1994; de la Fuente and Kocan 2003; de la Fuente et al. 2007a).